|Bid||129.00 x 1300|
|Ask||129.40 x 1100|
|Day's range||126.61 - 133.29|
|52-week range||17.91 - 178.50|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||N/A|
|Earnings date||24 Feb 2021 - 01 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||141.93|
The US pharmaceutical giant, which has partnered with Germany’s BioNTech, has slowed shipments and distribution proceeds unevenly among states in the European Union.
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.
Moderna (MRNA) closed at $124.06 in the latest trading session, marking a -0.39% move from the prior day.